CN106729283A - 一种用于家畜催情促孕的中药组合物及其制备方法 - Google Patents
一种用于家畜催情促孕的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN106729283A CN106729283A CN201611243274.9A CN201611243274A CN106729283A CN 106729283 A CN106729283 A CN 106729283A CN 201611243274 A CN201611243274 A CN 201611243274A CN 106729283 A CN106729283 A CN 106729283A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chinese
- medicine composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 100
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 230000001568 sexual effect Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 241001465754 Metazoa Species 0.000 title claims abstract description 22
- 230000000757 progestagenic effect Effects 0.000 title claims abstract description 22
- 241000522254 Cassia Species 0.000 claims abstract description 27
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 26
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 26
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 26
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 26
- 241000132012 Atractylodes Species 0.000 claims abstract description 25
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 25
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 25
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 25
- 239000009636 Huang Qi Substances 0.000 claims abstract description 24
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 23
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 23
- 210000004369 blood Anatomy 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000006071 cream Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 230000012173 estrus Effects 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000006196 drop Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 229940079593 drug Drugs 0.000 description 21
- 230000007812 deficiency Effects 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 13
- 239000000341 volatile oil Substances 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- -1 sublimed preparation Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 235000014590 basal diet Nutrition 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010044684 Trismus Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- VJGGHXVGBSZVMZ-QIZQQNKQSA-N Cloprostenol Chemical compound C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(Cl)=C1 VJGGHXVGBSZVMZ-QIZQQNKQSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 208000013228 adenopathy Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 229960004409 cloprostenol Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于家畜催情促孕的中药组合物及其制备方法,本发明的中药组合物,由以下重量配比的中药原料药制备而成:巴戟天15~25份,肉桂10~20份,高良姜10~20份,葫芦巴5~15份,黄芪5~15份,当归5~15份,熟地1~10份,红花1~10份,白术1~10份,山药1~10份。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种用于家畜催情促孕的中药组合物及其制备方法。
背景技术
目前动物养殖业的规模越来越大,走产业化发展,市场化发展道路。但是,由于外部因素的刺激不够,人工制造气候环境的影响,后备雌性动物不发情率高达40%,经产雌性动物也有15-20%,对于按计划生产的企业来讲,既提高生产成本,又增加不必要的劳动强度。针对这个问题,现有技术采用肌注孕马血清、氯前列醇等化学针剂催情,虽然可以使其发情,但是返情率和空怀率高达50%以上,产仔率低,流产概率高,而且不利用幼体的生长发育。中兽医应用中药治疗具有明显的优势,可避免以上弊端,但也存在一些问题亟需改进提高,诸如疗效不稳、处方庞大、给药不便等。
本发明提供一种用于家畜催情促孕的中药组合物及其制备方法,经临床试验表明,其催情效果好,为此本发明提供一种由巴戟天、肉桂、高良姜、葫芦巴、黄芪、当归、熟地、红花、白术、山药制备而成的中药,以补肾固冲、补气活血为主,具有催情促孕,提高家畜繁殖能力的作用。
发明内容
本发明的目的在于提供一种由巴戟天、肉桂、高良姜、葫芦巴、黄芪、当归、熟地、红花、白术、山药制备而成的中药,以补肾固冲、补气活血为主,具有催情促孕,提高家畜繁殖能力的作用。
为实现上述目的,本发明第一方面提供了一种用于家畜催情促孕的复方中药组合物,由以下重量配比的中药原料药制备而成:巴戟天15~25份,肉桂10~20份,高良姜10~20份,葫芦巴5~15份,黄芪5~15份,当归5~15份,熟地1~10份,红花1~10份,白术1~10份,山药1~10份。
优选的,由以下重量配比的中药原料药制备而成:巴戟天18~22份,肉桂13~18份,高良姜8~12份,葫芦巴8~12份,黄芪8~12份,当归8~12份,熟地2~8份,红花2~8份,白术2~8份,山药2~8份。
更优选的,由以下重量配比的中药原料药制备而成:巴戟天20份,肉桂15份,高良姜15份,葫芦巴10份,黄芪10份,当归10份,熟地5份,红花5份,白术5份,山药5份。
优选地,所述防治家畜催情促孕的中药组合物为片剂、胶囊剂、颗粒剂、丸剂、膏剂、溶液剂、注射剂、栓剂、喷雾剂、滴剂或贴剂。
本发明第二方面提供了一种用于家畜催情促孕的中药组合物的制备方法。具体地,所述方法包括以下步骤:
一、将巴戟天、肉桂、高良姜、葫芦巴、黄芪、当归、熟地、红花、白术及山药置于煎药器中,加水煎煮得到煎煮液;
二、将步骤一中的煎煮液过滤,静置8~12h,取上清液,50℃条件下减压浓缩至相对密度为1.21~1.27,经干燥制成干膏;
三、将步骤二中的所述干膏粉碎过筛后,加入糊精混匀,即制得用于家畜催情促孕的复方中药。
优选地,所述步骤一中的水为蒸馏水或去离子水。
优选地,所述步骤一中煎煮的方法为加入药材8~20倍质量的水,煮沸2~3次,每次煮沸2~4h;每次煮沸后分离滤液滤渣,在滤渣中加入药材10倍质量的水进行下一次煮沸。
优选地,所述步骤一中煎煮的时间为2h。
优选地,所述步骤三中过筛的孔径为100目。
本发明第三方面提供了一种用于家畜催情促孕的中药组合物的应用。具体地,所述用于家畜催情促孕的复方中药,用于治疗家畜气血不足、久不发情或产后发情慢等症状。
本发明具有如下优点:
1、本发明以巴戟天、肉桂、高良姜、葫芦巴、黄芪、当归、熟地、红花、白术及山药为原材料,利用现代先进的医药制药技术制成,具有材料易于取得,制备方法简单,低成本、易于大规模生产的特点。
2、本发明用于家畜催情促孕的中药组合物以君臣辅佐的配合组方,各药共奏,以补肾固冲、补气活血,达到催情促孕的效果。
3、本发明用于家畜催情促孕的中药组合物,有效的提高了家畜的发情率,缩短了产后发情间隔,适用于治疗母猪及牛羊的气血不足、久不发情或产后发情慢。
本发明所选用的中草药,其中,巴戟天为君药,肉桂、高良姜为臣药,葫芦巴、黄芪、当归、熟地、红花、白术为佐药,山药为使药。各味药材的药性及药理分别为:
巴戟天:味甘、辛、微温。归肾、肝经。温补肾阳,强筋骨,祛风湿。用于阳痿遗精,宫冷不孕,月经不调,少腹冷痛,风湿痹痛,筋骨痿软。巴戟天具有良好的调节免疫功能、调节甲状腺功能、抗衰老、抗疲劳、增强记忆、抗肿瘤、促进骨生长及促造血功能等作用。《神农本草经》:“主大风邪气,阳痿不起,强筋骨,安五脏,补中,增志,益气。”《本草纲目》:“治脚气,去风疾,补血海。”《本草备要》:“补肾益精,治五劳七伤,辛温散风湿,治风湿脚气水肿。”
肉桂:味甘幸、性大热。功能引火归源、温肾助阳、温中补阳、散寒止痛。主治腰膝冷痛、虚寒胃痛、慢性消化不良、肚痛吐泻、受寒经闭等症。《神农本草经》记载“味产温,主百病,养精神,和颜色,利关节,补中益气。为诸药先聘通使,久服通神,轻身不老”,《本草汇言》有“肉桂,治沉寒痼冷之药也”。《医学起源》记载“补下焦不足治沉寒痼冷”。
高良姜:性辛、热,归脾、胃经,具有温胃止呕、散寒止痛之功,常用于脘腹冷痛、胃寒呕吐、嗳气吞酸等证。现代药理学研究表明,高良姜还具有抗菌、抗病毒、抗肿瘤、抗氧化、抗胃肠道出血、抗溃疡和胃黏膜保护等作用。《本草汇言》:高良姜,祛寒湿、温脾胃之要药也。《本草纲目》:健脾胃,宽噎膈,破冷癖,除瘴疟。《本草求真》:良姜,同姜、附则能入胃散寒;同香附则能除寒祛郁。若伤暑泄泻,实热腹痛切忌。此虽与干姜性同,但干姜经炮经制,则能以去内寒,此则辛散之极,故能以辟外寒之气也。
葫芦巴:归肾、肝经。其性温味苦,具有温肾壮阳、祛寒除湿等功效;用于治疗寒疝、腹胁胀满、寒湿脚气、肾虚腰酸等。现代药理学研究表明,葫芦巴具有补肾壮阳、降血脂作用、抗炎、抗肿瘤降血脂等作用。《嘉祐本草》:主元脏虚冷气。得附子、硫黄,治肾虚冷,腹胁胀满,面色青黑;得蘹香子、桃仁,治膀胱气。《纲目》:治冷气疝瘕,寒湿脚气;益右肾,暖丹田。《国药的药理学》:为滋养强精药,用于阴痿、遗精及早泄。《四川中药志》:治寒泻。
黄芪:气微,味微甜,嚼之微有豆腥味。甘,温。归肺、脾经。补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。《药对》:“恶龟甲、白鲜皮。”《医学入门·本草》:“苍黑气盛者禁用,表实邪旺者亦不可用,阴虚者亦宜少用。”“畏防风。”
当归:味甘、辛,性温。归肝、心、脾经。功能主治:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。此外,当归还具有抗血栓,抗炎镇痛,降血糖,保肝利肝等作用。《本草经集注》:畏葛蒲、海藻、牡蒙。《药对》:恶湿面,畏生姜。《本草经疏》:肠胃薄弱,泄泻溏薄及一切脾胃病恶食、不思食及食不消,并禁用之,即在产后胎前亦不得入。
熟地:味甘、性平而入血分,功能滋阴补血、补精益髓。治阴虚血少,脑髓空虚所至的腰膝痿弱、劳嗽骨蒸,遗精,崩漏,月经不调,消渴,溲数,耳聋、目昏,心悸失眠、健忘,盗汗等。《珍珠囊》:“大补血虚不足,通血脉,益气力。”《医学启源》:“虚损血衰之人须用,善黑须发。《主治秘要》云:其用有五:益肾水真阴一也,和产后气血二也,去脐腹急痛三也,养阴退阳四也,壮水之源五也。”《纲目》:“填骨髓,长肌肉,生精血。”
党参:味甘,平。归脾、肺经。有补中益气,健脾益肺养血生津的功效。功能主治:脾胃虚弱,少食腹泻,肺虚咳喘,体倦无力,气虚垂脱。用于脾肺气虚,食少倦怠,咳嗽虚喘,气血不足,面色萎黄,心悸气短,津伤口渴,内热消渴。现代医学研究表明,党参具有调节血糖,促进造血机能,降压,抗缺氧,耐疲劳,增强机体免疫力,调节胃收缩及抗溃疡等多种作用。《本经逢原》:清肺。《本草从新》:补中益气,和脾胃,除烦渴。《纲目拾遗》:治肺虚,益肺气。《科学的民间药草》:补血剂。适用于慢性贫血,萎黄病,白血病,腺病,佝偻病。《中药材手册》:治虚劳内伤,肠胃中冷,滑泻久痢,气喘烦渴,发热自汗,妇女血崩、胎产诸病。
红花:味辛、温,入心、肝经。活血通经,去瘀止痛。治经闭,症瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。《唐本草》:治口噤不语,血结,产后诸疾。《开宝本草》:主产后血运口噤,腹内恶血不尽、绞痛,胎死腹中,并酒煮服。亦主蛊毒下血。《本草蒙筌》:喉痹噎塞不通,捣汁咽。《纲目》:活血,润燥,止痛,散肿,通经。《本草正》:达痘疮血热难出,散斑疹血滞不消。《本草再新》:利水消肿,安生胎,堕死胎。
白术:味甘性温而兼苦燥之性,甘温补气,苦燥健脾,归脾、胃经。功能主治:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。现代药理研究发现白术能抑制未孕小鼠离体子宫的自发收缩及对催产素、益母草引起的子宫兴奋性的收缩,并随着给药剂量的增加而抑制作用增强。《神农本草经》:术,味苦温。主风寒湿痹死肌,痉疸,止汗,除热,消食,作煎饵。久服轻身延年,不饥。《神农本草经》:术,味苦温。主风寒湿痹死肌,痉疸,止汗,除热,消食,作煎饵。久服轻身延年,不饥。
山药:味甘、平,归脾、肺、肾经。山药具有滋养强壮,助消化,敛虚汗,止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎。《神农本草经》谓之“主健中补虚、除寒热邪气、补中益气力、长肌肉、久服耳目聪明”;《本草纲目》认为山药能“益肾气、健脾胃、止泻痢、化瘫涎、润毛皮”。
本发明的中药组合物,在制备成药物制剂时,必要时可加入药物可接受的载体,按照制剂学的常规技术制备。其中的中药部分可以采用中药原料药制备得到,也可以通过共同提取中药原料得到,也可以通过其他方式得到,如:通过粉碎、压榨、煅烧、研磨、过筛、渗漉、萃取、水提、醇提、酯提、酮提、层析等方法得到中药活性物质、这些中药活性物质可以是浸膏形式的物质,可以是干浸膏也可以是流浸膏,根据制剂的不同需要决定制成不同的浓度。
本发明的药物制剂形式,以单位剂量形式存在,所述单位剂量形式是指制剂的单位,如片剂的每片,胶囊的每粒胶囊,颗粒剂每袋等。
本发明的中药制剂可以是任何可药用的剂型,这些剂型包括:片剂、胶囊剂、颗粒剂、丸剂、散剂、膏剂、丹剂、粉剂、注射剂、栓剂、喷雾剂、滴剂、贴剂。本发明的制剂,优选的是口服剂型,如:胶囊剂、片剂、口服液、颗粒剂、丸剂、散剂、丹剂、膏剂等。
本发明的中药组合物,其口服给药的制剂可含有常用的赋形剂,诸如粘合剂、填充剂、稀释剂、压片剂、润滑剂、崩解剂、着色剂、调味剂和湿润剂。适用的填充剂包括淀粉、蔗糖、纤维素、甘露糖醇、乳糖和其它类似的填充剂。适宜的崩解剂包括淀粉、聚乙烯吡咯烷酮和淀粉衍生物,例如羟基乙酸淀粉钠。适宜的润滑剂包括,例如硬脂酸镁。可通过混合,填充,压片等常用的方法制备固体口服组合物。进行反复混合可使活性物质分布在整个使用大量填充剂的那些组合物中;常用的辅料成分包括:甘露醇、山梨醇、焦亚硫酸钠、亚硫酸氢钠、硫代硫酸钠、盐酸半胱氨酸、巯基乙酸、蛋氨酸、维生素C、EDTA二钠、EDTA钙钠,一价碱金属的碳酸盐、醋酸盐、磷酸盐或其水溶液、盐酸、醋酸、硫酸、磷酸、氨基酸、氯化钠、氯化钾、乳酸钠、木糖醇、麦芽糖、葡萄糖、果糖、右旋糖苷、甘氨酸、淀粉、蔗糖、乳糖、甘露糖醇、硅衍生物、纤维素及其衍生物、藻酸盐、明胶、聚乙烯吡咯烷酮、甘油、土温80、琼脂、碳酸钙、碳酸氢钙、表面活性剂、聚乙二醇、环糊精、β-环糊精、磷脂类材料、高岭土、滑石粉、硬脂酸钙、硬脂酸镁等。
本发明的中药组合物,其中中药活性成分为0.1%-99.9%,赋形剂辅料为0.1%-和99.9%。
本发明的中药组合物在使用时根据情况确定用法用量,可以混料每日2~3次,每次按每吨饲料加入1%~5%剂量。
本发明进一步提供本发明的中药组合物的制备方法:
取药材加10~20倍量水煎煮三次,每次1~3小时,合并煎煮液,滤过,药液合并,减压浓缩至相对密度1.21~1.27(50℃)、干燥成干膏。干膏粉碎成细粉,加入辅料混匀,制成颗粒分装即得。
以下通过实验数据进一步说明本发明的有益效果。
实施例1
巴戟天40份,肉桂30份,高良姜30份,葫芦巴20份,黄芪20份,当归20份,熟地10份,红花10份,白术10份,山药10份。
制备过程如下:巴戟天40份,肉桂30份,高良姜30份,葫芦巴20份,黄芪20份,当归20份,熟地10份,红花10份,白术10份,山药10份等10位药材加10~20倍量水煎煮三次,每次1~3小时,合并煎煮液,滤过,静置过夜、滤取上清液,减压浓缩至相对密度1.21~1.27(50℃)、干燥成干膏。干膏粉碎过100目筛,加适量糊精混匀,即得散剂。
实施例2
巴戟天40份,肉桂30份,高良姜30份,葫芦巴20份,黄芪20份,当归20份,熟地10份,红花10份,白术10份,山药10份。
制备过程如下:各取肉桂30份、高良姜30份、当归20份、红花10份、白术10份等5味药材,加10~20倍量水,蒸馏2~8小时,提取挥发油,挥发油另器收集,挥发油与β-环糊精以1:10包合,备用;提取后的药渣,与巴戟天40份、葫芦巴20份、黄芪20份、熟地10份、山药10份,加10~20倍量水煎煮1~3次,每次1~3小时,合并煎煮液,过滤,减压浓缩至相对密度1.15~1.27(50℃),干燥,粉碎,过100目筛,干膏粉与挥发油β-环糊精包合物混合,加入适量糊精混匀,即得散剂。
实施例3
巴戟天20份,肉桂15份,高良姜15份,葫芦巴10份,黄芪10份,当归10份,熟地5份,红花5份,白术5份,山药5份
制备过程如下:取巴戟天20份、肉桂15份、高良姜15份、葫芦巴10份、黄芪10份、当归10份、熟地5份、红花5份、白术5份、山药5份等10位药材加10~20倍量水煎煮三次,每次1~3小时,合并煎煮液,滤过,静置过夜、滤取上清液,减压浓缩至相对密度1.21~1.27(50℃)、干燥成干膏。干膏粉碎过100目筛,加适量糊精混匀,加粘合剂,制粒,制成颗粒剂。
实施例4
巴戟天20份,肉桂15份,高良姜15份,葫芦巴10份,黄芪10份,当归10份,熟地5份,红花5份,白术5份,山药5份
制备过程如下:各取肉桂15份、高良姜15份、当归10份、红花5份、白术5份等5味药材,加10~20倍量水,蒸馏2~8小时,提取挥发油,挥发油另器收集,挥发油与β-环糊精以1:10包合,备用;提取后的药渣,与巴戟天40份、葫芦巴20份、黄芪20份、熟地10份、山药10份,加10~20倍量水煎煮1~3次,每次1~3小时,合并煎煮液,过滤,减压浓缩至相对密度1.15~1.27(50℃),干燥,粉碎,过100目筛,干膏粉与挥发油β-环糊精包合物混合,加入适量糊精混匀,加粘合剂,制粒,制成颗粒剂。
实施例5
巴戟天20份,肉桂15份,高良姜15份,葫芦巴10份,黄芪10份,当归10份,熟地5份,红花5份,白术5份,山药5份
制备过程如下:1)将肉桂15份、高良姜15份、当归10份、红花5份、白术5份分别粉碎、混合,置挥发油提取器中,加水浸泡2~3小时,加水的量为药材总重量的10~20倍以上。煮沸回流6h以上充分提取挥发油,备用,药液另器储存;2)在1)中提取挥发油后的药渣,与巴戟天20份、葫芦巴10份、黄芪10份、熟地5份、山药5份混合,加水煎煮3次,每次加入煎煮水的量为药材总重量的10~20倍,合并煎液,与1)中药液混合浓缩至原药材总量的0.5倍,加入乙醇,使醇的含量达60%,沉淀12h。回收乙醇后,再加入乙醇,使醇含量达70%,沉淀12h,回收乙醇,即得提取液,冷藏备用;3)取适量注射用水边加热边搅拌的情况下加入抗氧化剂亚硫酸氢钠36g溶解后,降温至40℃以下,加入1)中提取的挥发油和2)中所制备的提取液,搅拌均匀,加入适量的吐温-80使溶液澄明,在充氮状态下迅速搅拌至完全溶解,调pH值至4.5,加注射用水至总量10000ml,过滤,分装,充氮,封口,灭菌,即得口服液。
试验例1
本中药对母猪不孕症的治疗结果:
试验药物:上述实施例所制畜禽催情的中药组合物。
试验动物:断奶7d不发情的3~5胎长白、大白经产母猪96头。
试验方法:断奶7d不发情的96头经产母猪于断奶第8天,随机分为4组,分别为对照组、试验Ⅰ组、试验Ⅱ组和试验Ⅲ组。
对照组饲喂基础日粮。试验Ⅰ组饲喂实施例1方法制备的中药组合物,按照每吨基础日粮添加3%进行拌料饲喂治疗,5天为一个疗程;试验Ⅱ组饲喂除去君药巴戟天的中药组合物,制备方法和饲喂方法同试验Ⅰ组;试验Ⅲ组饲喂除去臣药肉桂的中药组合物,制备方法和饲喂方法同试验Ⅰ组。应用上述实施例所制畜禽催情的中药组合物对不发情的母猪进行治疗,结果见表1、表2。
表1催情促孕的中药复方对母猪的催情效果
注:*:表示P<0.05。
表2催情促孕的中药复方对母猪产仔情况的影响
试验结果表明,本发明显著提高断奶7d不发情的母猪的发情率、受胎率,产仔率、产健子数都显著高于对照组。同时,显著降低弱仔数、死胎数和木乃伊数。去除君药和使药后,结果与对照组无显著变化,但试验Ⅲ组结果优于试验Ⅱ组。结果表明,本发明的组合物效果最好,缺君药、使药后结果均下降。
实验例2
本发明对不孕奶牛的治疗效果
试验药物:上述实施例所制畜禽催情的中药组合物。
试验动物:产后2~4个月不发情奶牛200头,分为4组,各50头。分别为对照组、试验Ⅰ组、试验Ⅱ组和试验Ⅲ组。
试验方法:对照组饲喂基础日粮。试验Ⅰ组饲喂实施例1方法制备的中药组合物,按照每吨基础日粮添加3%进行拌料饲喂治疗,5天为一个疗程;试验Ⅱ组饲喂除去君药巴戟天的中药组合物,制备方法和饲喂方法同试验Ⅰ组;试验Ⅲ组饲喂除去臣药肉桂的中药组合物,制备方法和饲喂方法同试验Ⅰ组。
应用上述实施例所制畜禽催情的中药组合物对不同时间不发情的奶牛进行治疗,结果见表3。
表3催情促孕的中药复方对奶牛乏情治疗的影响
注:*:表示P<0.05。
试验结果表明,本发明中药复方治疗奶牛乏情1个疗程后,平均发情率达到84%,总治愈率为90.5%,对照组平均发情率为48%,发情奶牛受胎率为62.5%。试验Ⅰ组平均发情率及总治愈率都明显高于对照组,试验Ⅱ组与对照组无显著差异,试验Ⅲ组优于对照组和试验Ⅱ组,治疗效果比试验Ⅰ组差。由此证明,本发明的中药组合物全方有良好的催情促孕效果,缺失其中的君药或使药,都会影响到最终的治疗效果。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,本领域技术人员利用上述揭示的技术内容做出些许简单修改、等同变化或修饰,均落在本发明的保护范围内。
Claims (10)
1.一种用于家畜催情促孕的中药组合物,由以下重量配比的中药原料药制备而成:巴戟天15~25份,肉桂10~20份,高良姜10~20份,葫芦巴5~15份,黄芪5~15份,当归5~15份,熟地1~10份,红花1~10份,白术1~10份,山药1~10份。
2.根据权利要求1所述的中药组合物,其特征在于,由以下重量配比的中药原料药制备而成:巴戟天18~22份,肉桂13~18份,高良姜8~12份,葫芦巴8~12份,黄芪8~12份,当归8~12份,熟地2~8份,红花2~8份,白术2~8份,山药2~8份。
3.根据权利要求1所述的中药组合物,其特征在于,由以下重量配比的中药原料药制备而成:巴戟天20份,肉桂15份,高良姜15份,葫芦巴10份,黄芪10份,当归10份,熟地5份,红花5份,白术5份,山药5份。
4.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物为片剂、胶囊剂、颗粒剂、丸剂、膏剂、溶液剂、注射剂、栓剂、喷雾剂、滴剂或贴剂。
5.权利要求1所述的中药组合物的制备方法,其特征在于,包括以下步骤:
一、将巴戟天、肉桂、高良姜、葫芦巴、黄芪、当归、熟地、红花、白术及山药置于煎药器中,加水煎煮得到煎煮液;
二、将步骤一中的煎煮液过滤,静置8~12h,取上清液,50℃条件下减压浓缩至相对密度为1.21~1.27,经干燥制成干膏;
三、将步骤二中的所述干膏粉碎过筛后,加入糊精混匀,即制得用于家畜催情促孕的复方中药。
6.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述步骤一中的水为蒸馏水或去离子水。
7.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述步骤一中煎煮的方法为加入药材8~20倍质量的水,煮沸2~3次,每次煮沸2~4h;每次煮沸后分离滤液滤渣,在滤渣中加入药材10倍质量的水进行下一次煮沸。
8.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述步骤一中煎煮的时间为2h。
9.根据权利要求5所述的中药组合物的制备方法,其特征在于,所述步骤三中过筛的孔径为100目。
10.权利要求1所述的中药组合物的应用,用于家畜催情促孕,用于治疗家畜气血不足、久不发情或产后发情慢等症状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611243274.9A CN106729283A (zh) | 2016-12-29 | 2016-12-29 | 一种用于家畜催情促孕的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611243274.9A CN106729283A (zh) | 2016-12-29 | 2016-12-29 | 一种用于家畜催情促孕的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106729283A true CN106729283A (zh) | 2017-05-31 |
Family
ID=58923736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611243274.9A Pending CN106729283A (zh) | 2016-12-29 | 2016-12-29 | 一种用于家畜催情促孕的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106729283A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308432A (zh) * | 2017-07-11 | 2017-11-03 | 重庆振辉牧业科技有限公司 | 一种空怀母猪催情散及其制备方法 |
CN108354077A (zh) * | 2018-03-07 | 2018-08-03 | 余姚辉农农业科技有限公司 | 一种初产母猪用饲料添加剂、饲料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491649A (zh) * | 2014-12-04 | 2015-04-08 | 郭志平 | 一种促进母猪发情提高产仔率及催乳功能的中药制剂 |
CN105497412A (zh) * | 2015-12-16 | 2016-04-20 | 孙自富 | 一种促进母羊发情排卵的药剂及其制备方法 |
-
2016
- 2016-12-29 CN CN201611243274.9A patent/CN106729283A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491649A (zh) * | 2014-12-04 | 2015-04-08 | 郭志平 | 一种促进母猪发情提高产仔率及催乳功能的中药制剂 |
CN105497412A (zh) * | 2015-12-16 | 2016-04-20 | 孙自富 | 一种促进母羊发情排卵的药剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
程观宝: ""八珍汤"加减治疗经产母猪不发情", 《中兽医医药杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308432A (zh) * | 2017-07-11 | 2017-11-03 | 重庆振辉牧业科技有限公司 | 一种空怀母猪催情散及其制备方法 |
CN108354077A (zh) * | 2018-03-07 | 2018-08-03 | 余姚辉农农业科技有限公司 | 一种初产母猪用饲料添加剂、饲料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103734428B (zh) | 一种提高免疫力的女贞子保健茶及其制备方法 | |
CN103734548B (zh) | 用于治疗猪消化不良的饲料及其制备方法 | |
CN103690919B (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN103251873A (zh) | 一种消食化积的中兽药 | |
CN102488848A (zh) | 治疗高致病性猪蓝耳病的中药组合物、制备方法和应用 | |
CN104162094A (zh) | 一种治疗肥胖型多囊卵巢综合征的中药组合物及其药物制剂 | |
CN104398991A (zh) | 一种治疗奶牛缺乳症的药物组合物及其制备方法 | |
CN104258139A (zh) | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 | |
CN109718303A (zh) | 提高女性卵巢功能养颜美容改善女性皮肤的中药组合物 | |
KR101600751B1 (ko) | 녹용을 함유하는 여성 불임증 치료용 한약 조성물 제조 방법 | |
CN102688389B (zh) | 用于治疗猪高热综合征的中药组合物、饲料、及制备方法 | |
CN106729283A (zh) | 一种用于家畜催情促孕的中药组合物及其制备方法 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN103784754A (zh) | 一种补肾壮阳胶囊及制备方法 | |
CN105211441A (zh) | 一种降压降脂的丹参叶保健茶及其制备方法 | |
CN104208524A (zh) | 用于治疗仔猪痢疾的药物 | |
CN104922538A (zh) | 一种用于IgA肾病中药制剂及其制备方法 | |
CN103705835B (zh) | 用于治疗僵猪的药物及其制备方法 | |
CN105797112A (zh) | 一种具有缓释效果的治疗母猪子宫炎的饲料添加剂 | |
CN106620066A (zh) | 一种用于家畜催情促孕的中药组合物及其制备方法 | |
CN104435962A (zh) | 用于治疗仔猪消化不良性下痢的药物组合物及其制备方法 | |
CN104324332A (zh) | 一种治疗肝郁气滞型黄褐斑的中药制剂及其制备方法 | |
CN103877324A (zh) | 用于提高蛋鸡产蛋量的中药添加剂及其制备方法 | |
CN103610991B (zh) | 用于治疗猪胃溃疡的药物及其制备方法 | |
CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |
|
RJ01 | Rejection of invention patent application after publication |